This European multi-center post-CE Mark study continues the evaluation of dissection repair with the Tack Endovascular System following DCB angioplasty with the IN.PACT Admiral in the SFA and proximal popliteal arteries. The study enrolled 169 patients with standard lesions ≤150mm, and 32 patients with long lesions >150mm and ≤250mm.

Toba III

Standard Lesion Key Results1:

97.7%

Dissection Resolution

97.5%

12m K-M Freedom
from CD-TLR

95.0%

12m K-M
Primary Patency

0.6%

Bail Out Stent Rate


Long Lesion Key Results:

98.8%

Dissection Resolution

96.8%

12m K-M Freedom
from CD-TLR

89.3%

12m K-M
Primary Patency

0.0%

Bail Out Stent Rate

100% dissected vessel population

To learn more about TOBA III, click here »

Hear the results from the TOBA III study during a roundtable discussion with Thomas Zeller, MD, Marianne Brodmann, MD (principal investigator), and Michael Lichtenberg, MD.


This multi-center, pivotal trial studied the Tack Endovascular System in patients with a post-PTA dissection following POBA or Lutonix® DCB in the SFA and proximal popliteal arteries.* The trial enrolled 213 patients with at least one post-PTA dissection, with 69.4% adjudicated as severe.

Toba II

Key Results2:

92.1%

Dissection Resolution

86.5%

12m K-M Freedom
from CD-TLR

79.3%

12m K-M
Primary Patency

0.5%

Bail Out Stent Rate

100% dissected vessel population


The Tack Endovascular System is a first-of-its-kind minimal metal implant that effectively repairs dissections and improves post-angioplasty outcomes regardless of balloon choice.

Learn More
TOBA III Metal Implant